PARP Inhibitors for Patients with Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer — An Interview with Dr Wassim Abida episode artwork

EPISODE · May 15, 2026 · 51 MIN

PARP Inhibitors for Patients with Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer — An Interview with Dr Wassim Abida

from Prostate Cancer Update

Dr Wassim Abida from Memorial Sloan Kettering Cancer Center in New York, New York, discusses the role of PARP inhibitors in the management of hormone-sensitive and castration-resistant metastatic prostate cancer.CME information and select publications here.

NOW PLAYING

PARP Inhibitors for Patients with Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer — An Interview with Dr Wassim Abida

0:00 51:55

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

The Laura Ingraham Show Laura Ingraham The most-watched woman in the history of cable news brings her no-holds-barred political and cultural commentary to podcasting with The Laura Ingraham Show. A bestselling author, breast cancer survivor, and mother of three internationally adopted children, Laura was the most listened-to woman in talk radio before launching her own podcast. A trailblazer across media platforms, she brings a unique perspective to this twice-weekly show, drawing on her experience as a white-collar criminal defense litigator and a Supreme Court law clerk.New episodes drop twice a week—delivering the clarity, courage, and common sense America needs. Lynne's Podcast Lynne August MD Dr. A offers her interpretations and applications of Dr. Revici’s profound research at DrRevici.com and the Revici Journal. Dr. Revici was arguably fifty to one hundred years ahead of his time in his application of quantum physics to medical sciences. As a once-aspiring physicist, this alone propelled Dr. A to Dr. Revici. As a physician, she felt compelled, and in some palpable way responsible, to understand Dr. Revici’s ability to control pain and achieve remissions in terminal cancer patients with his non-toxic “guided chemotherapy”, even many cancers that conventional therapy failed to control. Most of the time his questions and solutions were as unprecedented as they were effective. While Dr. Revici was primarily focused on cancer, Dr. A’s research and therapeutics to prevent and treat all chronic and degenerative disease can transform 21st century medicine. Agrifood Brief Euractiv Welcome to EURACTIV's AgriFood Brief, your weekly update on all things Agriculture & Food in the EU from EURACTIV's Agrifood news team: Gerardo Fortuna and Natasha Foote

Frequently Asked Questions

How long is this episode of Prostate Cancer Update?

This episode is 51 minutes long.

When was this Prostate Cancer Update episode published?

This episode was published on May 15, 2026.

What is this episode about?

Dr Wassim Abida from Memorial Sloan Kettering Cancer Center in New York, New York, discusses the role of PARP inhibitors in the management of hormone-sensitive and castration-resistant metastatic prostate cancer.CME information and select...

Can I download this Prostate Cancer Update episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!